Overexpression of HOXB13 predicts poor prognosis in patients with colon cancer
Authors:
Open Access
- 14 June 2022
- journal article
- letter
- Published by Elsevier in Asian Journal of Surgery
- Vol. 45 (12) , 2788-2789
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Colorectal cancerThe Lancet, 2019
- Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trialThe Lancet Gastroenterology & Hepatology, 2019
- HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyOncotarget, 2015
- TNM Staging System of Colorectal Carcinoma: A Critical Appraisal of Challenging IssuesArchives of Pathology & Laboratory Medicine, 2010